Collegium Announces FDA Tentative Approval for Xtampza(TM) ER, a Novel Abuse-Deterrent Analgesic for Chronic Pain
November 09, 2015 at 06:05 AM EST
Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced that the United States Food and Drug Administration (FDA) has granted ...
